How do antimalarial drugs reach their intracellular targets?

Drugs represent the primary treatment available for human malaria, as caused by Plasmodium spp. Currently approved drugs and antimalarial drug leads generally work against parasite enzymes or activities within infected erythrocytes. To reach their specific targets, these chemicals must cross at le...

Full description

Bibliographic Details
Main Authors: Katherine eBasore, Yang eCheng, Ambuj K. Kushwaha, Son T. Nguyen, Sanjay A. Desai
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00091/full
_version_ 1819036868249911296
author Katherine eBasore
Yang eCheng
Ambuj K. Kushwaha
Son T. Nguyen
Sanjay A. Desai
author_facet Katherine eBasore
Yang eCheng
Ambuj K. Kushwaha
Son T. Nguyen
Sanjay A. Desai
author_sort Katherine eBasore
collection DOAJ
description Drugs represent the primary treatment available for human malaria, as caused by Plasmodium spp. Currently approved drugs and antimalarial drug leads generally work against parasite enzymes or activities within infected erythrocytes. To reach their specific targets, these chemicals must cross at least three membranes beginning with the host cell membrane. Uptake at each membrane may involve partitioning and diffusion through the lipid bilayer or facilitated transport through channels or carriers. Here, we review the features of available antimalarials and examine whether transporters may be required for their uptake. Our computational analysis suggests that most antimalarials have high intrinsic membrane permeability, obviating the need for uptake via transporters; a subset of compounds appear to require facilitated uptake. We also review parasite and host transporters that may contribute to drug uptake. Broad permeability channels at the erythrocyte and parasitophorous vacuolar membranes of infected cells relax permeability constraints on antimalarial drug design; however, this uptake mechanism is prone to acquired resistance as the parasite may alter channel activity to reduce drug uptake. A better understanding of how antimalarial drugs reach their intracellular targets is critical to prioritizing drug leads for antimalarial development and may reveal new targets for therapeutic intervention.
first_indexed 2024-12-21T08:12:21Z
format Article
id doaj.art-323409c4712b4201b0ec29c9720fc060
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-21T08:12:21Z
publishDate 2015-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-323409c4712b4201b0ec29c9720fc0602022-12-21T19:10:38ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122015-05-01610.3389/fphar.2015.00091136202How do antimalarial drugs reach their intracellular targets?Katherine eBasore0Yang eCheng1Ambuj K. Kushwaha2Son T. Nguyen3Sanjay A. Desai4National Institutes of HealthNational Institutes of HealthNational Institutes of HealthMicrobiotixNational Institutes of HealthDrugs represent the primary treatment available for human malaria, as caused by Plasmodium spp. Currently approved drugs and antimalarial drug leads generally work against parasite enzymes or activities within infected erythrocytes. To reach their specific targets, these chemicals must cross at least three membranes beginning with the host cell membrane. Uptake at each membrane may involve partitioning and diffusion through the lipid bilayer or facilitated transport through channels or carriers. Here, we review the features of available antimalarials and examine whether transporters may be required for their uptake. Our computational analysis suggests that most antimalarials have high intrinsic membrane permeability, obviating the need for uptake via transporters; a subset of compounds appear to require facilitated uptake. We also review parasite and host transporters that may contribute to drug uptake. Broad permeability channels at the erythrocyte and parasitophorous vacuolar membranes of infected cells relax permeability constraints on antimalarial drug design; however, this uptake mechanism is prone to acquired resistance as the parasite may alter channel activity to reduce drug uptake. A better understanding of how antimalarial drugs reach their intracellular targets is critical to prioritizing drug leads for antimalarial development and may reveal new targets for therapeutic intervention.http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00091/fullAntimalarialsPlasmodium falciparumdrug absorptionDrug Uptakeplasmodial surface anion channellipid diffusion of drugs
spellingShingle Katherine eBasore
Yang eCheng
Ambuj K. Kushwaha
Son T. Nguyen
Sanjay A. Desai
How do antimalarial drugs reach their intracellular targets?
Frontiers in Pharmacology
Antimalarials
Plasmodium falciparum
drug absorption
Drug Uptake
plasmodial surface anion channel
lipid diffusion of drugs
title How do antimalarial drugs reach their intracellular targets?
title_full How do antimalarial drugs reach their intracellular targets?
title_fullStr How do antimalarial drugs reach their intracellular targets?
title_full_unstemmed How do antimalarial drugs reach their intracellular targets?
title_short How do antimalarial drugs reach their intracellular targets?
title_sort how do antimalarial drugs reach their intracellular targets
topic Antimalarials
Plasmodium falciparum
drug absorption
Drug Uptake
plasmodial surface anion channel
lipid diffusion of drugs
url http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00091/full
work_keys_str_mv AT katherineebasore howdoantimalarialdrugsreachtheirintracellulartargets
AT yangecheng howdoantimalarialdrugsreachtheirintracellulartargets
AT ambujkkushwaha howdoantimalarialdrugsreachtheirintracellulartargets
AT sontnguyen howdoantimalarialdrugsreachtheirintracellulartargets
AT sanjayadesai howdoantimalarialdrugsreachtheirintracellulartargets